2023-04-28
Redeye Orphan Drug Day
CEO Magnus Corfitzen presents at Redeye Orphan Drug Day
Presentations & Articles
2023-03-30
HC Andersen – Orviglance commercial opportunity and progress towards launch
Deputy Chief Executive Officer & CCO presents at HC Andersen
2023-02-16
HC Andersen – Q4 2022 highlights and Q&A
Chief Executive Officer presents at HC Andersen - Q4 2022 highlights and Q&A
2022-09-13
ABGSC Investor Day
CEO Magnus Corfitzen presents at ABG Investor Day
2022-05-31
HC Andersen – Oncology Seminar
Chief Executive Officer presents at HC Andersen Oncology Seminar
2022-05-19
Erik Penser Bank – Company Day
Chief Executive Officer presents at Erik Pensers Company Day
2022-04-27
Redeye Orphan Drug Day
Chief Medical Officer, Carl Bjartmar presents at Redeye Orphan Drug Day
2022-02-24
Erik Penser Bank – Life Science day
Chief Commercial Officer Julie Waras Brogren presents at Erik Pensers Life Science day
2022-01-31
Ascelia Pharma – Aktiedagen in Lund 2022
Chief Commercial Officer presents at Aktiedagen in Lund
2022-01-20
Redeye Fight Cancer Seminar 2022
VP of R&D Andreas Norlin presents at Redeye Fight Cancer Seminar
2021-12-07
HC Andersen Capital seminar – Re-read Study Orviglance vs. Gadolinium
CEO Magnus Corfitzen presents results from the re-read study vs. a gadolinium contrast agent (presentation in Danish)
2021-11-25
Erik Penser Bank – Company day
CEO Magnus Corfitzen presents at Erik Penser company day.
2021-11-11
Redeye Life Science Day 2021
Ascelia Pharma CEO Magnus Corfitzen presents at Redeye Life Science Day.
2021-11-04
Q3 2021 Financial Presentation
The Executive Managment in Ascelia Pharma presents a business update and the quarterly results
2021-10-06
HC Andersen/Nordea Small & Mid Cap Seminar
CEO Magnus Corfitzen presents at the Danish HC Andersen/Nordea Small & Mid cap seminar (presentation in Danish)
2021-09-30
Erik Penser Bank – Orphan Drugs Day
CEO Magnus Corfitzen presents how Ascelia Pharma advances orphan drugs
2021-09-28
Swedish Shareholders’ Association
CMO Carl Bjartmar presents Ascelia Pharma at the Swedish Shareholders' Association's share day
2021-09-27
Clinical collaboration with Taiho Oncology
CEO Magnus Corfitzen presents the clinical collaboration with Taiho Oncology (in Danish)